Recent advances in acute promyelocytic leukaemia
نویسندگان
چکیده
Acute promyelocytic leukaemia (APML) is a subtype of leukaemia arising from a distinct reciprocal translocation involving chromosomes 15 and 17, which results in the PML-RARA fusion gene. Over the past three decades, APML has been transformed from a highly fatal disease to a highly curable one. This drastic improvement is because of the introduction of a new treatment strategy with all-trans retinoic acid and, more recently, arsenic trioxide. The revolutionary treatment of APML has also paved the way for a new cancer treatment, which is genetically targeted therapy. In this review, we look into this amazing journey of transformation and provide recent advances in the management of APML.
منابع مشابه
Pediatric haematopoiesis and related malignancies
Survival after acute paediatric (0-14 years), adolescent (15-19 years) and young adult (20-39 years) leukaemia has improved substantially over the last five decades, particularly for acute lymphoblastic leukaemia (ALL) and acute promyelocytic leukaemia. This progress represents one of the most successful achievements in the history of medicine and has been attributed to the development of effec...
متن کاملبررسی اثرات ضد تومور و تمایزی آلکالوییدهای هارمین و هارمالین روی سلولهای لوسمیک درمان شده با ATRA و G-CSF
In acute leukaemia, the maturation of the malignant cells is arrested and the cells merely proliferate. In the recent years, beside chemotherapy combination of differential factors cytokins and cytotoxic agents have been used in treatment of acute leukaemia particularly acute promyelocytic leukaemia. The present study was an evaluation of proliferation, cytotoxicity and differentiatio...
متن کاملAn trans-retinoic acid in the treatment of promyelocytic leukaemia - a case report
Acute Promyelocytic Leukaemi.a (APML) is an uncommon type of acute non-lymphocytic leukaemia (ANLL)l. Treatment of APML is associated with significant mortality and morbidity. Ten to twenty per cent of the patients die early of fatal haemorrhage resulting from coagulopathy and sepsis. An alternative approach to the treatment of APML has centered on the use of differentiating agents to induce re...
متن کاملOf mice and men – are mice relevant models for human disease
Mouse research has lead to major advances in our ability to treat a number of serious diseases and conditions. For example, work on mice resulted in successful treatments for a cancer (acute promyelocytic leukaemia, or APL) that was previously largely untreatable. The EU has long been aware of the usefulness of mice in research and since 1998 has invested EUR 550 million in over 180 projects in...
متن کاملAcute promyelocytic leukaemia with a novel translocation t(16;17)(q12;p13): a case report.
Acute promyelocytic leukaemia (APML) is characterised by the t(15;17)(q22;q21), that results in the fusion of the promyelocytic leukaemia (PML) gene at 15q22 with the retinoic acid α-receptor (RARA) gene at 17q21. The current case report describes a 13-year-old male with APML, who was negative for PML/RARA fusion signal but reported to have an atypical translocation t(16;17). To the best of our...
متن کامل